Psychiatric disorders are common and complex and their precise biological underpinnings remain elusive. Multiple epidemiological, molecular, genetic and gene expression studies suggest that immune system dysfunction may contribute to the risk for developing psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder. However, the precise mechanisms by which inflammationrelated events confer such risk are unclear. In this review, we examine the peripheral and central evidence for inflammation in psychiatric disorders and the potential molecular mechanisms implicated including inhibition of neurogenesis, apoptosis, the HPA-axis, the role of brain-derived neurotrophic factor and the interplay between the glutamatergic, dopaminergic and serotonergic neurotransmitter systems.
introduction
The etiopathogenesis of many psychiatric disorders remain poorly understood despite the identification of multiple contributing factors, including immune system, genetic and environmental factors including stress Huntington's disease, and multiple sclerosis but also in cerebrovascular disorders [16] and major psychiatric disorders such as MDD, SZ and BD [17, 18] .
The process of inflammation is complex and regulated either directly or indirectly by a number of soluble molecules such as cytokines, chemokines, and acute phase proteins. Since many of these molecules, especially cytokines, can influence cognition and behaviour, they are thought to play a significant role in behavioural disorders [19] [20] [21] . [33, 34] . The data from multiple immunological studies revealing elevated levels of peripheral inflammatory markers in major psychiatric disorders are presented in Table 1 . It is now well recognised that the inflammatory response depends on the genetic background of the individual. The extent of the inflammatory response is determined by variability in genes encoding mediators that constitute the inflammatory pathways [35] . Several studies have revealed that gene variants that contribute to an augmented inflammatory response are associated with the pathogenesis of many diseases including psychiatric disorders [36, 37] . Independent genetic polymorphism (Table 2 ) and gene expression (Table 3) In addition, there is now evidence that receptors for the pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6 and the IFNs, are constitutively expressed in the hippocampus, thalamus, hypothalamus, dentate gyrus and cortex [90] . BBB function is compromised in certain conditions including vascular, inflammatory and infectious diseases and in several brain pathologies [91] . BBB breakdown will increase the transport of peripheral cytokines into the brain, thus inducing the activation of astrocytes, microglia, and recruitment of immune cells.
Prolonged systemic inflammation in neonatal rats can lead to a change in BBB permeability, structure of some blood vessels and later in life subsequent changes in behaviour have been observed [92] . Indications of BBB dysfunction in SZ has come from studies showing elevated albumin and IgG in the CSF [93, 94] . In addition, abnormalities in the brain microvasculature have been linked to the etiology of psychosis [95, 96] . Inflammation of the cerebral microvasculature has been proposed as a source of BBB dysfunction in SZ [97] . Abnormalities arise because genetically modulated inflammatory reactions damage the microvascular system in response to environmental agents such as infections, hypoxia, and physical trauma. The inflamed micro-vessels lose their coupling with astrocytes, leading to disrupted regulation of cerebral blood flow and damage to the BBB.
Such disruptions in homeostatic mechanisms
of the brain might lead to abnormal signal processing and contribute to psychosis [97] . In addition to this, brain injuries that often involve BBB breakdown and astrocytic response increase the risk of significant neuropsychiatric conditions, including personality changes, depression, anxiety, dementia and perhaps psychosis [98, 99] . Cytokine receptors are expressed in glia and neuronal cells throughout the human brain, albeit at low levels relative to the periphery [102] . The cytokines that are expressed in healthy CNS include IL-1α, IL1-1β, IL-4, IL-6, IL-10, IL-11, IL-13, IL-18, TNF-α, IL-1Ra, TGF-β, and CCL2 [104] . Although most of the cytokines in the CNS are produced by astrocytes and/ or microglia, neurons can also secrete cytokines under certain conditions [105] . Usually, the expression of cytokines is augmented in response to specific stimuli such as infection or injury however there is evidence that low-level expression of specific cytokines is constitutive in blood vessels within the brain [106] . Cytokines in the brain perform two major functions: local inflammatory responses and neuromodulation [86] . Under physiological conditions activation of the inflammatory machinery in the brain may be an important mechanism involved in normal neuronal function and synaptic plasticity [107] . In the hippocampus for example, IL-1 and TNF have been shown to modulate longterm potentiation and glutamate dependent synaptic plasticity [108] . However, under conditions of chronic stress and in pathological states including depression, the oxidative stress pathway dominates resulting in reduced tissue repair [123] .
Apoptosis
Chronic stress is known to precipitate depression-like behaviours in animals, and can increase the susceptibility of certain populations of neurons to cell death [124, 125] . Apoptosis is a highly regulated process of cell death. Under physiological conditions, apoptosis plays an important role in pruning damaged neurons, a critical part of normal brain development [126] .
The caspases are a family of cysteine proteases that are closely involved in promoting cell death through apoptosis or inflammation [127, 128] . 
Neurotransmitter systems
Glutamate is the principal excitatory neurotransmitter in the brain and is known to be involved in a variety of physiological thereby play a role in the regulation of cross talk between melatonin and the kynurenine pathways [180] .
In contrast in SZ, it has recently been suggested that glutamatergic hypofunction might be responsible for dopaminergic dysfunction [181] . Although, the mechanisms underlying these pathways are yet to be identified, it is increasingly recognised that the function of glutamatergic system is closely related to the immune system and tryptophan-kynurenine metabolism. Therefore, The tryptophan-kynurenine pathway in the brain is regulated closely by microglia and astrocytes [188] . Microglial cells preferentially produce QA while astrocytes are the main source of KA production [189] [190] [191] . Under physiological conditions, the activity of the tryptophan-kynurenine pathway is minimal and balance is maintained between the neurotoxic and neuroprotective arms of the pathway. expression of inflammatory messengers [212] [213] [214] . It has been shown that GC secretion due to stress increases sensitivity to LPSinduced inflammation in the mouse brain [215] .
In addition, GC also exacerbates glutamateinduced neuronal loss [216] . Inflammation reduces GC signalling at glucocorticoid receptors (GR) and has been implicated in the pathophysiology of depressive disorders [146] .
3. Stress decreases the expression of BDNF and antidepressant treatment reverses this effect [155] . In addition, acute stress that increases the expression of pro-inflammatory cytokines, including IL-1β has been shown to inhibit BDNF synthesis [217] . with psychotic symptoms [197] . A number of studies have also reported increased levels of KA in the CSF and prefrontal cortex of patients with SZ [198] [199] [200] . KA is shown to inhibit the release of glutamate, which subsequently may inhibit the release of dopamine as its release is regulated in part by glutamatergic activity [201] . Increased levels of KA in the brain might lead to glutamatergic hypofunction in SZ. This A relationship between an increased genetic risk for higher production of IL-1 and brain volume loss in SZ has been reported [245] .
IL-6 is found to increase the concentration of superoxide that causes a degeneration of interneurons expressing calcium binding protein parvalbumin (PV) [246] . A dysfunction of the PV-interneurons is thought to be a key feature of SZ. Morphological changes such as reduction in glial cell numbers and size and packing density of cortical neurons in the fronto-limbic region [247] as well as a decrease in the volumes of the prefrontal cortex, amygdala and hippocampus have been widely reported to occur in depression [248] [249] [250] . Changes such as the latter, could be the consequences of chronic low grade inflammation [251] .
conclusion
Cumulatively research over the decades has established the link between the immune system and susceptibility to psychiatric Although research focusing on antiinflammatory treatment approaches in psychiatric disorders is relatively sparse, it is emerging as one of the promising alternative therapeutic strategies [256, 257] . A recent study has shown that anti-inflammatory therapy (using selective COX-2 inhibitor celecoxib) has significant impact on the depressive symptoms [258] . In addition, the TNF-α antagonist infliximab has been assessed in depressed older adults, though depressive symptoms disappeared in some patients, the findings did not yield very conclusive results [259] . Despite these advances, as inflammation influences apoptotic pathways and components such as GC and BDNF, involved in neural development and plasticity, any attempt to design the anti-inflammatory drugs for the treatment of psychiatric disorders should also consider these factors. 
